Annual Total Long Term Liabilities
$1.03 B
+$720.79 M+231.53%
31 December 2023
Summary:
ImmunityBio annual total long term liabilities is currently $1.03 billion, with the most recent change of +$720.79 million (+231.53%) on 31 December 2023. During the last 3 years, it has risen by +$760.37 million (+279.82%). IBRX annual total long term liabilities is now at all-time high.IBRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$1.05 B
-$31.82 M-2.95%
30 September 2024
Summary:
ImmunityBio quarterly total long term liabilities is currently $1.05 billion, with the most recent change of -$31.82 million (-2.95%) on 30 September 2024. Over the past year, it has increased by +$295.03 million (+39.19%). IBRX quarterly long term liabilities is now -2.95% below its all-time high of $1.08 billion, reached on 30 June 2024.IBRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +231.5% | +39.2% |
3 y3 years | +279.8% | +209.1% |
5 y5 years | - | - |
IBRX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +279.8% | -3.0% | +237.8% |
5 y | 5 years | at high | +279.8% | -3.0% | +285.6% |
alltime | all time | at high | +279.8% | -3.0% | +285.6% |
ImmunityBio Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.05 B(-2.9%) |
June 2024 | - | $1.08 B(+4.0%) |
Mar 2024 | - | $1.04 B(+0.6%) |
Dec 2023 | $1.03 B(+231.5%) | $1.03 B(+37.1%) |
Sept 2023 | - | $752.74 M(+133.1%) |
June 2023 | - | $322.93 M(+4.1%) |
Mar 2023 | - | $310.17 M(-0.4%) |
Dec 2022 | $311.31 M | $311.31 M(-56.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $711.18 M(+95.6%) |
June 2022 | - | $363.64 M(+5.1%) |
Mar 2022 | - | $346.13 M(+0.7%) |
Dec 2021 | $343.83 M(+26.5%) | $343.83 M(+1.4%) |
Sept 2021 | - | $338.96 M(+2.6%) |
June 2021 | - | $330.46 M(+4.9%) |
Mar 2021 | - | $314.90 M(+15.9%) |
Dec 2020 | $271.74 M | $271.74 M |
FAQ
- What is ImmunityBio annual total long term liabilities?
- What is the all time high annual total long term liabilities for ImmunityBio?
- What is ImmunityBio annual total long term liabilities year-on-year change?
- What is ImmunityBio quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ImmunityBio?
- What is ImmunityBio quarterly long term liabilities year-on-year change?
What is ImmunityBio annual total long term liabilities?
The current annual total long term liabilities of IBRX is $1.03 B
What is the all time high annual total long term liabilities for ImmunityBio?
ImmunityBio all-time high annual total long term liabilities is $1.03 B
What is ImmunityBio annual total long term liabilities year-on-year change?
Over the past year, IBRX annual total long term liabilities has changed by +$720.79 M (+231.53%)
What is ImmunityBio quarterly total long term liabilities?
The current quarterly long term liabilities of IBRX is $1.05 B
What is the all time high quarterly long term liabilities for ImmunityBio?
ImmunityBio all-time high quarterly total long term liabilities is $1.08 B
What is ImmunityBio quarterly long term liabilities year-on-year change?
Over the past year, IBRX quarterly total long term liabilities has changed by +$295.03 M (+39.19%)